MedPath

Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center

Phase 4
Conditions
Radial Artery Injury
Interventions
Drug: NTG 1 MG/ML Injectable Solution
Registration Number
NCT03889470
Lead Sponsor
Hermina Heart Center Kemayoran
Brief Summary

The investigators will investigate whether administration of Nitroglycerin (NTG) as spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in patients undergoing transradial catheterization in radial center.

Detailed Description

Patients will be randomized to receive either 200 microgram NTG or placebo (saline) at the beginning of the procedure soon after radial sheath placement. The operators will be blinded to both assignment. The primary outcome is the incidence of moderate to severe RAS evaluated by the operators during the radial procedure.

Both NTG and placebo will be administered using an identical syringe to keep the operators blinded to the treatment allocation. Radial angiogram is mandatory to measure the diameter of both radial and ulnar arteries. Doppler ultrasound of the radial artery will be examined at the day after the procedure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • All patients undergoing transradial catheterisation using proximal radial artery puncture technique
Exclusion Criteria
  • Blood pressure <100 mmHg
  • Refuse to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SalineNTG 1 MG/ML Injectable SolutionSaline infusion through the radial sheath
200 microgram NTGNTG 1 MG/ML Injectable Solution200 microgram NTG through the radial sheath
Primary Outcome Measures
NameTimeMethod
The incidence of Moderate to severe radial artery spasmDuring the index procedure

arm pain associated with catheter manipulation (RAS grade 2 to 4)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hermina Heart Center

🇮🇩

Jakarta Pusat, DKI Jakarta, Indonesia

Hermina Heart Center
🇮🇩Jakarta Pusat, DKI Jakarta, Indonesia
Surya Dharma, MD, PhD
Contact
+622122608771
drsuryadharma@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.